All Stories

  1. Animal Models in Neuroscience: What Is the “Culture of Care”?
  2. Animal Models in Neuroscience: What “Culture of Care”?
  3. Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human
  4. Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease From Mice to Human
  5. Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
  6. Mitochondrial Bioenergy in Neural Disease: Huntington and Parkinson
  7. Mitochondrial Bioenergy in Neural Disease: Huntington and Parkinson
  8. Alpha‐Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction
  9. Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
  10. Postsynaptic autism spectrum disorder genes and synaptic dysfunction
  11. Exploitation of Thermal Sensitivity and Hyperalgesia in a Mouse Model of Dystonia
  12. Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia
  13. Effect of Gabapentin in a Neuropathic Pain Model in Mice Overexpressing Human Wild-Type or Human Mutated Torsin A
  14. The neuroligins and the synaptic pathway in Autism Spectrum Disorder
  15. Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data
  16. Optogenetic Activation of Striatopallidal Neurons Reveals Altered HCN Gating in DYT1 Dystonia
  17. Impaired dopamine- and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia
  18. The neurobiological basis for novel experimental therapeutics in dystonia
  19. Novel therapeutic target in DYT1 dystonia
  20. Synaptic Plasticity Changes: Hallmark for Neurological and Psychiatric Disorders
  21. Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum
  22. Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition
  23. Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia
  24. Synaptic plasticity alterations in the dorsal striatum of the R451C-Neuroligin3 model of ASD
  25. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia
  26. Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice
  27. Dopamine-dependent CB 1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice
  28. Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons
  29. Cerebellar synaptogenesis is compromised in mouse models of DYT1 dystonia
  30. Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons
  31. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia
  32. Opposite changes of Phosphodiesterase-10A in striato-pallidal and striato-entopeduncular pathways of TorsinA DYT1 transgenic mice
  33. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia
  34. Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1muscarinic receptors
  35. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia
  36. Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum
  37. PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity
  38. Torsin A Localization in the Mouse Cerebellar Synaptic Circuitry
  39. Critical role of calcitonin gene-related peptide receptors in cortical spreading depression
  40. Cholinergic Dysfunction Alters Synaptic Integration between Thalamostriatal and Corticostriatal Inputs in DYT1 Dystonia
  41. Aberrant striatal synaptic plasticity in monogenic parkinsonisms
  42. Developmental Profile of the Aberrant Dopamine D2 Receptor Response in Striatal Cholinergic Interneurons in DYT1 Dystonia
  43. Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission
  44. Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease
  45. Experimental Models of Dystonia
  46. Centrality of Striatal Cholinergic Transmission in Basal Ganglia Function
  47. Electrophysiology of 5-HT6 Receptors
  48. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine
  49. Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+currents and intracellular Ca2+increase in rat cortical neurons in vitro
  50. Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia
  51. Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin
  52. Distinct roles of group I mGlu receptors in striatal function
  53. Loss of Muscarinic Autoreceptor Function Impairs Long-Term Depression But Not Long-Term Potentiation in the Striatum
  54. Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum
  55. Impaired dopamine release and synaptic plasticity in the striatum of PINK1 -deficient mice
  56. Functional and ultrastructural analysis of group I mGluR in striatal fast-spiking interneurons
  57. Endogenous Serotonin Excites Striatal Cholinergic Interneurons via the Activation of 5-HT 2C, 5-HT6 and 5-HT7 Serotonin Receptors: Implications for Extrapyramidal Side Effects of Serotonin Reuptake Inhibitors
  58. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia
  59. NR2B Subunit Exerts a Critical Role in Postischemic Synaptic Plasticity
  60. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease
  61. Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons
  62. Mitochondrial Toxins in Basal Ganglia Disorders: From Animal Models to Therapeutic Strategies
  63. Pathological Synaptic Plasticity in the Striatum: Implications for Parkinson's Disease
  64. Inhibition of Persistent Sodium Current Fraction and Voltage-gated L-type Calcium Current by Propofol in Cortical Neurons: Implications for Its Antiepileptic Activity
  65. Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons
  66. Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons
  67. Calcium signaling and neuronal vulnerability to ischemia in the striatum
  68. Intracellular Calcium Increase in Epileptiform Activity: Modulation by Levetiracetam and Lamotrigine
  69. Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons
  70. Targeting striatal cholinergic interneurons in Parkinson's disease: Focus on metabotropic glutamate receptors
  71. Stimulus frequency, calcium levels and striatal synaptic plasticity
  72. Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons
  73. Impairment of mitochondrial metabolism differentially affects striatal neuronal subtypes
  74. Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation
  75. Dopamine-Dependent Long-Term Potentiation Induced by 3-Nitropropionic Acid in Striatal Medium Spiny Neurons
  76. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons
  77. Presynaptic modulation by group III metabotropic glutamate receptors (mGluRs) of the excitatory postsynaptic potential mediated by mGluR1 in rat cerebellar Purkinje cells
  78. Selective involvement of mGlu1 receptors in corticostriatal LTD
  79. Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons
  80. An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease
  81. Role of tonically-active neurons in the control of striatal function: Cellular mechanisms and behavioral correlates
  82. Cell-type specificity of mGluR activation in striatal neuronal subtypes
  83. Involvement of Intracellular Calcium Stores during Oxygen/Glucose Deprivation in Striatal Large Aspiny Interneurons
  84. Toxicity of Selected Plant Volatiles in Microbial and Mammalian Short-term Assays
  85. Aflatoxin B1 is an inhibitor of cyclic nucleotide
  86. Activities of 3′:5′ cyclic nucleotide phosphodiesterases in the superior cervical ganglion of rat: Characterization, compartmentalization and observations in young and old animals
  87. Short and Long Term Modulation of Synaptic Activity in Striatal Cholinergic Interneurons